Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma

计划入组 495 人 · 首次发布于 2008 年 9 月 8 日

sCLEC-2 in Stroke Study

计划入组 600 人 · 首次发布于 2022 年 10 月 13 日

Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma

计划入组 5 人 · 首次发布于 2024 年 3 月 19 日

Ulviprubart

natural killer cell therapy

allogeneic natural killer T-like cell like therapy (cancer)

G1 Therapeutics

United States

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Abcuro Secures $200M Series C to Advance Phase II/III Trial for Rare Muscle Disease Treatment

Abcuro Secures $200M Series C Funding to Advance Novel IBM Treatment Ulviprubart

Abcuro's Ulviprubart Misses Primary Endpoints in Inclusion Body Myositis Trial, Shows Promise in Mild-to-Moderate Patients